5-BROMO-1-ETHYL-3-IODO-1H-PYRROLO[2,3-C]PYRIDINE, 95.0%, 5g

3-Methylphenylboronic Acid (contains varying amounts of Anhydride)1g

4-Bromo-3-ethyl-1H-pyrazole, 95.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-hydroxyphenyl)propanoic acid, 97%, 1g

Plan PLi 2x/0.05 IOS infinity corrected objective, no cover glass correction. Working distance 18.3mm

1-(4-AMINO-2,6-DIFLUOROPHENYL)PIPERIDIN-4-OL, 95.0%, 100mg

(2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 95.0%, 500g

Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)praseodymium(III) [NMR Shift Reagent]>98.0%(T)1g

2-Fluoro-6-methoxypyridine, 95.0%, 25g

ECHINACOSIDE, 98%, 250mg

2-Hydroxy-4-methylpentanoic acid, 95.0%, 25g

2-chloro-N-[(furan-2-yl)methyl]-7H-purin-6-amine, 97%, 10g

3-Ethoxy-2-nitropyridine, 97.0%, 25g